We also found that primary breast cancer tissues that either were poorly differentiated (grade 3), lacked expression of estrogen receptors, or were triple negative, generally expressed higher levels of ROR1 than primary breast cancer tissues without such poor-prognostic features (Fig. 2B, S1B–C). This evidence concerns the gene ROR1 and breast carcinoma.